Christine Ring, Chief Legal Officer at Nurix Therapeutics, Inc. (NRIX), sold 11,008 shares at $23.56 ($259K) on 2026-07-02, disclosed to the SEC on 2026-07-02.
Scheduled sale ($259k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NRIX | SELL | 2026-08-03 | $382K | — | Filing → |
| NRIX | SELL | 2026-07-30 | $90K | — | Filing → |
| NRIX | SELL | 2026-06-25 | $581K | — | Filing → |